Poviodine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Poviodine

Property Description
Active Ingredient Povidone-Iodine (PVP-I) complex
Pharmacological Class Antiseptic, Germicide, Iodophor
Common Forms Topical Solution, Ointment, Surgical Scrub
Route of Administration Topical use (Cutaneous, Mucosal)
Origin Synthetic Complex Compound

What Type of Medicine is Povidone-Iodine (Poviodine)?

Povidone-Iodine is a synthetic broad-spectrum antimicrobial agent classified primarily as an antiseptic and germicide, serving a foundational role in topical hygiene and preparation. It is the widely accepted International Nonproprietary Name (INN) for this active ingredient, which is also commonly known under various brand names. The compound belongs to the high-level pharmacological class of Iodophors, which are complex compounds where active elemental iodine is loosely bound to the carrier molecule, Povidone (Polyvinylpyrrolidone). This chemical structure is crucial as it significantly reduces the stinging and staining historically associated with older, simpler iodine preparations. This specific formulation provides comparable broad-spectrum efficacy to traditional iodine but with lower irritation potential. The core general purpose of this medicine is the swift elimination or significant reduction of microbial presence on the skin or mucous membranes.

Composition, Origin, and Available Drug Forms

The active ingredient in this medication is the Povidone-Iodine complex (PVP-I), which functions as a single-component active agent derived from a synthetic origin. This substance acts as a reservoir to ensure the controlled and sustained release of free iodine, the component responsible for the microbial destruction, an action clinically recognized for its efficacy in infection control. The mechanism of action is based on non-selective microbial destruction through oxidation, effective against bacteria (bactericidal), fungi (fungicidal), viruses (virucidal), and spores (sporicidal). This topical use compound is available in various dosage forms, including the familiar topical antiseptic solution, ointment, and specialized preparations like a surgical scrub. This variety ensures the germicide can be applied effectively to different anatomical sites, such as using the solution form for pre-operative skin preparation or the ointment form for minor abrasions.

Regulatory References

  1. Povidone-Iodine - DailyMed
  2. Label: POVIDONE-IODINE solution - DailyMed

What side effects are possible with Poviodine?

Possible side effects and safety information

The safety characteristics of Povidone-Iodine (Poviodine) are officially defined by local reactions and the potential for systemic effects resulting from iodine absorption. The most commonly reported events are categorized under Skin and Subcutaneous Tissue Disorders.

Local sensitivity reactions, such as irritation, itching, or redness (pruritus or erythema), are frequently documented. The official classification states that hypersensitive skin reactions and delayed contact-allergic reactions are classified as Rare in regulatory documents.

Systemic Safety Concerns

Significant adverse reactions are linked to the systemic uptake of iodine, typically occurring after prolonged use or application over large surface areas, such as extensive wounds or burns. These effects can involve multiple organ systems:

  • Endocrine Disorders: Risk of Iodine-induced hyperthyroidism (classified as Very Rare), particularly in patients with pre-existing thyroid conditions, and the potential for hypothyroidism.
  • Renal and Urinary Disorders: Serious reactions include acute renal failure.
  • Immune System Disorders: Life-threatening generalized allergic reactions, such as anaphylactic reactions or anaphylactic shock, are documented as serious adverse reactions.

Population-Specific Constraints

The medicine is subject to specific regulatory constraints for vulnerable populations. It is officially contraindicated for individuals with manifest hyperfunction of the thyroid (hyperthyroidism). For neonates and small infants, use must be kept to the absolute minimum due to the risk of inducing hypothyroidism, and regular application is contraindicated. Use during pregnancy and lactation should only occur if strictly indicated and kept to a minimum.

Overdose and Emergency Response

Overdose with Poviodine is associated with the risk of systemic iodine toxicity, primarily resulting from accidental oral ingestion or excessive, prolonged application to large areas of broken skin. Documented clinical presentations of overdose include metabolic acidosis, hypernatremia, and severe gastrointestinal symptoms such as nausea, vomiting, and abdominal pain, along with corrosive irritation following ingestion.

The official regulatory profile notes the potential for severe and life-threatening outcomes due to this systemic toxicity. These complications include acute renal failure, circulatory collapse (shock), and serious thyroid dysfunction, which may manifest as either hypo- or hyperthyroidism.

Due to the severity of these risks, regulatory guidance is explicit: seek immediate medical attention or contact a poison control center immediately if an overdose is suspected. The product must be discontinued, and medical supervision or hospitalization is required for observation. Management is strictly symptomatic and supportive, as no specific antidote is known. Monitoring must include close observation of vital signs, renal function, electrolyte status, and potential thyroid imbalance. Regulatory labeling also highlights increased risk for infants and neonates due to greater systemic absorption, and notes caution for individuals with pre-existing renal or thyroid disorders.

Therapeutic Uses of Poviodine

Povidone-Iodine is a broad-spectrum antiseptic relevant in contexts involving microbial control across various topical applications. It is commonly used as a first aid antiseptic and for preoperative skin preparation, aligning with its core therapeutic domains.

Management of Minor Cuts, Scrapes, and Superficial Wounds

This medication plays a role in managing symptoms related to minor breaks in skin integrity, such as scrapes, small abrasions, and superficial burns. Its main benefit is supporting the reduction of microbial contamination in these acute surface wounds, which generally helps reduce the risk of localized infection symptoms.

Infection Prophylaxis in Surgical and Clinical Settings

Povidone-Iodine is applied in hospital environments where its use as an antiseptic wash or scrub may assist with reducing the risk of complications. This application provides supportive relief and is relevant for easing the microbial burden in the context of Surgical Site Infection (SSI) prophylaxis.

Quick Fact: Relief for Microbial Risk
Supports the patient by easing the microbial burden in minor cuts and scrapes, contributing to a sense of stability during symptomatic periods.

Regulatory References

  1. NIH DailyMed Label for Povidone Iodine Solution

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

The eligibility profile for Poviodine (Povidone-Iodine) is established by regulatory bodies through specific contraindications and restrictions, primarily related to the potential for systemic iodine absorption.

Absolute Contraindications (Must Not Use)

Use of this medicine is strictly prohibited for individuals with a known hypersensitivity to iodine, Povidone, or any excipients. It is also formally contraindicated in patients with a diagnosis of manifest hyperfunction of the thyroid (hyperthyroidism) or other manifest thyroid diseases, as well as those undergoing treatment with radioactive iodine.

Restricted and Conditional Use Populations

Eligibility is highly restricted for specific physiological states and age groups:

  • Pediatric Use: The medicine is generally not recommended for newborn and small infants due to the high risk of iodine absorption potentially leading to hypothyroidism.
  • Pregnancy and Lactation: Use during these periods is restricted and must only occur when strictly indicated and kept to the absolute minimum, as iodine can be transferred.
  • Comorbidities: Patients with pre-existing non-manifest thyroid disorders or impaired renal function require restricted use and special caution. General OTC eligibility is established for adults and children 12 years of age and older, but application over large skin areas or for prolonged periods is restricted.

What should I know about interactions with other medicines?

The official interaction profile for Poviodine (Povidone-Iodine) is structured around chemical incompatibilities and the potential systemic effects stemming from iodine absorption, as documented in regulatory sources.

Interaction Type Interacting Substance/Class Official Regulatory Statement
Pharmacodynamic Antiseptic/Disinfectants Co-administration with hydrogen peroxide, taurolidine, or silver-containing proteins impairs the efficacy of both agents due to chemical reaction.
Mercury Compounds Contraindicated due to the risk of forming corrosive mercury iodide compounds upon co-application.
Enzymatic Agents Must be avoided with enzymatic wound treatment agents, as the antiseptic action weakens the effect of the enzyme components.
Systemic/Exposure Radioiodine Iodine absorption from Poviodine interferes with radioiodine diagnostic tests and may compromise the efficacy of therapeutic radioiodine uptake.
Lithium Regular application is to be avoided in patients receiving lithium therapy due to a potential synergistic effect that increases the risk of hypothyroidism.

Official labeling mandates that a waiting period of at least one to two weeks should be observed after discontinuing Poviodine before performing certain thyroid scans. The product must not be used concomitantly with mercury-based or octenidine-based disinfectants. These restrictions define the product's official interaction constraints, primarily addressing co-administration hazards and interference with diagnostic procedures.

Mechanism of Action

Direct Chemical Destruction of Microbial Life

The primary mechanism involves the non-selective oxidation and iodination of microbial components. The active agent, free iodine (I2), rapidly attacks essential cellular targets—including proteins (enzymes and structural components), lipids, and nucleic acids—causing irreversible damage. This chemical assault leads swiftly to the denaturation and coagulation of the microbial cell contents, resulting in rapid germicidal action against a broad spectrum of bacteria, viruses, and fungi.


⏳ Controlled Release and Sustained Action

The Povidone component acts not as an active agent, but as a chemical reservoir or carrier, binding the elemental iodine. This complex ensures the sustained and gradual release of the active free iodine at the site of application. This crucial delivery mechanism maintains a concentration of the oxidizing agent over time, supporting the mechanism's ability to target less susceptible microbial forms.


️ Constraint by Competing Organic Matter

The activity of this chemical mechanism is physiologically constrained by the presence of organic material like blood, pus, or tissue debris. These materials contain proteins and other molecules that are also susceptible to non-selective oxidation by the free iodine. This competition consumes the active agent, lowering the available concentration of free iodine.

Dosage and Administration Information

How Povidone-Iodine is Used

This section describes the administration principles and use patterns for Povidone-Iodine (Poviodine). This product is limited to topical (cutaneous) and ophthalmic routes of administration.


Administration Routes and Forms

Preparations include solutions, surgical scrubs, and ointments, primarily available at 10% (solution/ointment) and 7.5% (surgical scrub) concentrations for external use. A 5% solution is also specified for pre-operative ophthalmic cleansing.


Dosing Patterns and Frequency

Usage frequency varies based on the product’s intended role and the specific formulation:

  • First Aid Antiseptic: The 10% solution or ointment is applied up to 3 times daily. Usage is typically restricted to a short-term course, generally not exceeding 7 days, unless directed by a healthcare professional.

  • Procedural Use: For both patient pre-operative skin preparation and surgical hand scrubbing, the product is applied in a single application or a two-stage process. For instance, a surgical hand scrub involves using approximately 5 mL for each of two successive scrub procedures.


Preparation and Administration Specifics

Proper use requires adherence to key procedural constraints. For cutaneous application, the affected area must be cleaned beforehand, and the solution must be allowed to dry completely prior to covering or draping. When used for ophthalmic preparation, the 5% solution is applied to the eye(s), typically for a 2-minute contact time, and then must be thoroughly flushed away with sterile saline. The solution must not be allowed to pool under the patient during surgery preparation.


Population-Specific Notes

Use in children under 12 years should be discussed with a healthcare professional. For ophthalmic use, the adult regimen may be used in infants and children, though use in newborns under 1 month may be restricted.

Recent Clinical Evidence

Poviodine: Recent Clinical Evidence


Evidence for Use in Preoperative and Clinical Skin Antisepsis

Poviodine was studied for its application as a skin antiseptic before surgery through Randomized Controlled Trials (RCTs) and meta-analyses involving adult patients. The research explored the measured incidence of Surgical Site Infection (SSI) and monitored immediate changes in bacterial counts on the skin. Findings describe patterns observed in the studies regarding SSI rates, but comparative studies with newer agents show that findings were mixed when establishing a consistent pattern across different surgical settings. The results apply only to the populations studied, and some regulatory reviews have noted that additional data are needed to fully satisfy contemporary standards for certain health care antiseptic uses.


Evidence for Use as a First Aid Antiseptic in Minor Wounds

The research exploring the topical use of Poviodine for minor cuts and scrapes includes in vitro laboratory studies and comparative clinical trials. These studies monitored outcomes related to the prevention of localized infection and the rate of wound healing (e.g., time to complete healing). In vitro data suggests measured rapid activity against microorganisms. However, clinical trials findings indicate that measured healing times did not consistently show accelerated patterns compared to simple controls. Regarding limitations, some laboratory research monitored whether standard concentrations were associated with changes in the growth of cells essential for wound repair. Comparative evidence is lacking to definitively show an advantage in accelerating healing.


Long-Term Evidence, Special Populations, and Uncertainty

Major clinical trials, particularly for surgical prophylaxis, generally focus on intermediate-term follow-up, typically observing patients for up to 30 days post-procedure. Research exploring long-term effects are not fully established beyond these critical short-term periods. The evidence predominantly was evaluated in adult patients, and data for certain groups remain insufficient, especially for special populations (such as pregnant individuals, infants, or the very elderly) and those with compromised immunity. Overall, certainty remains low in areas like consistent comparative performance and the cellular-level findings related to wound healing, which is an area where research is ongoing.

Key Studies & References

  1. Povidone-Iodine Solution, USP Labeling and Monograph Information

Frequently Asked Questions (FAQ)

Common questions about Poviodine (FAQ)


Q: Does Poviodine generally cause stinging or burning when applied to minor injuries?

Povidone-Iodine is formulated to be less irritating than older, simpler forms of iodine. However, official safety documentation notes that local sensitivity reactions, such as irritation or burning, have been reported rarely. If constant irritation, burning, or itchiness develops during use, regulatory guidance indicates a need for consultation with a healthcare professional.


Q: Are there any known issues with Poviodine for people with sensitive skin?

Regulatory documents note that the product may make certain pre-existing skin conditions worse. For this reason, official labeling indicates that individuals with known skin conditions or sensitivity should consult a healthcare professional before use.


Q: What should be done if Poviodine accidentally gets into the eye?

The official product information strongly advises keeping the antiseptic solution out of the eyes. If accidental contact occurs, official information describing accidental exposure states that the eyes should be rinsed immediately and thoroughly with plenty of cool tap water or regular water.


Q: Does Poviodine permanently stain clothing or skin?

Yes, Povidone-Iodine products can cause staining on both the skin and clothing. One specific warning indicates that white gold jewelry should be removed before use, as the solution has the potential to permanently discolor it.


Q: How quickly does the antiseptic action of Poviodine begin after application?

In laboratory studies, Povidone-Iodine demonstrates rapid germicidal activity. Some clinical guidelines indicate that the antiseptic effect can begin after as little as 30 seconds of contact. However, official recommendations often require a longer minimum contact time to achieve the intended full effect.


Q: Is it safe to use Poviodine products for vaginal cleansing?

Povidone-Iodine is officially available in specific dosage forms, such as pessaries or suppositories, which are used for treating certain vaginal infections. The topical antiseptic solution, however, is formally defined for cutaneous (skin) use only.


Q: What is the main difference between Poviodine and a topical antibiotic cream?

Povidone-Iodine is classified as a broad-spectrum antiseptic, which works by a non-selective chemical process like oxidation to destroy a wide variety of germs (bacteria, viruses, and fungi). Topical antibiotic creams, in contrast, work through selective mechanisms that primarily target susceptible bacteria.


Q: Why does the Poviodine solution have a recognizable brown color?

The recognizable brown color of the solution is a chemical characteristic directly related to the active ingredient. It is caused by the presence of elemental iodine, which is loosely bound within the Povidone complex.


Q: Does the color of Poviodine indicate how effective it is?

The color of the solution is directly linked to the presence of the active iodine component. Official information indicates that a visible loss of the solution’s brown color may suggest that the product is no longer effective.


Q: Can Poviodine be used on a wound that has already started to develop redness or swelling?

Povidone-Iodine is indicated for the management of minor trauma or infection. The official label includes a warning stating that use should be stopped and a healthcare professional consulted if the condition persists or gets worse. Redness or swelling may be signs that the condition is worsening or requires assessment by a healthcare provider.


Q: Can Poviodine be applied to open wounds or is it for intact skin only?

The product is indicated for minor trauma or infection of the skin, which may include broken skin. However, official warnings note that iodine absorption occurs through broken skin and burns. Regulatory warnings state that the product is not for use over large areas of the body or for deep, puncture wounds.


Q: Are there specific warnings for using Poviodine on deep puncture wounds or animal bites?

Official labeling indicates that consultation with a healthcare professional is necessary before use in case of deep or puncture wounds, animal bites, or serious burns. This recommendation is due to the potential for serious infection and the risk of increased iodine absorption in these conditions.


Q: Can individuals with certain skin disorders, like eczema, use Poviodine?

Official labeling indicates that individuals should consult a healthcare professional if they have any pre-existing skin conditions or sensitivity. This guidance is in place because the official product information indicates the medication may make certain skin conditions worse.


Q: Are there any metals or materials that should not come into contact with Poviodine?

Regulatory information states that the product must not be used concomitantly with other products containing mercury or silver. Furthermore, official warnings state that the solution can permanently discolor white gold jewelry and that it should be removed before application.


Q: Is there research evidence regarding Poviodine's effectiveness against antibiotic-resistant bacteria?

Povidone-Iodine is an antiseptic that works through a non-selective process of oxidation, which is associated with a much lower risk of bacterial resistance selection compared to antibiotics. Official information notes that its broad spectrum of activity is effective against many organisms, including those for which resistance to antibiotics has been documented.

How should Poviodine be stored and disposed of?

Official Storage and Disposal Requirements

Regulatory agencies define specific conditions for storing and disposing of Poviodine to maintain the stability of the antiseptic complex.

Storage/Disposal Aspect Official Regulatory Requirement
Storage Temperature Store at controlled room temperature, typically 15 C to 30 C (59 F to 86 F), and avoid excessive heat.
Environmental Protection The product must be protected from freezing and stored away from light.
Container Integrity The container must be kept tightly closed when not in use.
Child Safety Keep out of the sight and reach of children is a mandatory storage rule.
Disposal Unused or expired product must be disposed of according to local regulations. General guidance directs avoiding environmental release of waste.

Official labeling mandates controlled temperature and protection from light and freezing to prevent degradation. Disposal must follow the instructions defined by local authorities for unused medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Poviodine found in:

A-Z Index: